Thu, Aug 21, 2014, 9:38 AM EDT - U.S. Markets close in 6 hrs 22 mins

Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • konshedafa konshedafa Apr 6, 2013 2:56 PM Flag

    Sell on the news, Buy on the rumer. This rull is good for this stock because PPS have no earninbg support!!!

    Anural report said: As a result of our substantial research and development expenditures and minimal product revenues, we have incurred cumulative losses of $326.5 million through December 31, 2012, and have not consistently generated enough funds through our operations to support our business. Although we were profitable in the last three years, we expect to have operating losses over the next few years and we may never achieve sustained profitability.
    2013 company expect lose 30mm or 0.32 a shares. once 1Q earning report coming out, PPS could be down.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You have the same spelling problems that Mero/aka rory has shown lately. "Buy on the rumer. This rull is good for this stock because PPS have no earninbg support"

      Sentiment: Strong Buy

      • 1 Reply to kyjellie
      • Here are a few of Mero's spelling errors:

        He awarded himself a most load of $10 optionsHe nght sell for less
        I would fee better if Man uso were hone
        Don't forget about 2 billion in potential molstone payments for Astex purchased compounds.
        Needs to go much higher just to recoop lost Dacogen dividend and Astex investment
        Spam don't go therefore

        Looks like mero and konshedafa having troubles on their vowels.

        Sentiment: Strong Buy

 
ASTX
8.4950.000(0.00%)Oct 10 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.